GLIOMATCH 5th Consortium Meeting
2026-04-27 08:00 - 2026-04-29 17:00 (Europe/London) | SJD, Barcelona, Spain
The 5th Consortium Meeting is held in Barcelona, Spain, from 27 to 29 April 2026 and hosted by Hospital Sant Joan de Déu (HSJD).

AACR American Association for Cancer Research Annual Meeting 2026
2026-04-17 08:00 - 2026-04-22 17:00 | San Diego Convention Center, San Diego, California, United States
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
Key Dates

November 18, 2025: Regular/First Abstract Submission Deadline
January 5, 2026: Early Registration Deadline
January 12, 2026: Clinical Trials/Late-Breaking Abstract Submission Deadline
February 27, 2026: Advance Registration Deadline

World Health Day 2026
2026-04-07

2nd annual meeting of the U-THI-Clust
2026-03-23 | Nencki Institute, Warsaw, Poland
The 2nd annual meeting of the U-THI-Clust is held in Warsaw, Poland and hosted by HIT-GLIO at the Nencki Institute.

BTAM Brain Tumour Awareness Month
2026-03-01 08:00 - 2026-03-31 17:00

7th Glioblastoma Drug Development Summit 2026
2026-02-17 08:00 - 2026-02-19 17:00 | GBM drug development summit 2026, Boston, MA, United States
Innovating Novel Combination Therapies & Maximising Preclinical & Clinical Development to Improve Glioblastoma Targeting & Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in Need

The glioblastoma drug development space has been energized by Merck’s acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged by limited investment and clinical breakthroughs.
Looking ahead to 2026, it’s crucial to sustain this momentum. The 7th Glioblastoma Drug Development Summit is your essential platform for accelerating new treatments and continuing this vital progress.

International Day of Women & Girls in Science
2026-02-11

World Cancer Day 2026
2026-02-04

SNO Society for Neuro-Oncology Annual Meeting 2025
2025-11-19 08:00 - 2025-11-23 17:00 | SNO 2025, Honolulu, Hawaii, United States
Make your plans to attend the 7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, held in conjunction with the 30th Society for Neuro-Oncology Annual Meeting & Education Day in beautiful Honolulu, Hawaii! This year’s meeting is particularly special, as we celebrate SNO’s 30th anniversary—a milestone that underscores three decades of progress, collaboration, and innovation in neuro-oncology.
The World Federation of Neuro-Oncology Societies (WFNOS) serves as an international collaborative platform that unites neuro-oncology organizations from around the world. By fostering global partnerships, WFNOS aims to advance research, education, and clinical care for patients with tumors of the central nervous system. Held every four years, the WFNOS Quadrennial Meeting is hosted by one of its charter societies, and in 2025, it is SNO’s privilege to bring this prestigious gathering to the United States.

GLIOMATCH 4th Consortium Meeting (online)
2025-11-17
The 4th GLIOMATCH consortium meeting is held online on 17 November 2025 and focuses on scientific discussions and stakeholder involvement, including the distribution of the GLIOMATCH patient survey.

GLIOMATCH 3rd Consortium Meeting
2025-03-25 08:00 - 2025-03-27 17:00 | UDUS, Düsseldorf, Germany
From 25 to 27 March 2025, the GLIOMATCH consortium convened in Düsseldorf, Germany, for its third consortium meeting. The meeting was held in-person and hosted by the partner University of Düsseldorf (UDUS). Over 40 experts from across Europe gathered to assess progress of the past year and plan the next phase of the GLIOMATCH project.

1st annual meeting of the U-THI-Clust
2025-01-31 | IDIBAPS’ Esther Koplowitz Centre, Barcelona, Spain
The first annual meeting of the EU Cancer Mission‘s Understanding (tumour-host interactions) Cluster held in January 2025 brought together leading cancer researchers, policymakers, and patient representatives at IDIBAPS’ Esther Koplowitz Centre in Barcelona. The event, organised by the THRIVE project, aimed to strengthen collaboration and shape policies to advance Europe’s fight against cancer, in line with the EU’s Beating Cancer Plan.
Partners KUL and CPE attended in person. KUL presented the data mangement and UNCAN collaboration topics, while CPE addressed patient inequalities. accelopment joined online to support with communication and dissemination topics.

GLIOMATCH 2nd Consortium Meeting (online)
2024-09-20
The GLIOMATCH 2nd consortium meeting was held online in September 2024 and focused on discussing work progress in scientific work packages.

Kick-off cluster meeting (online)
2024-04-05
The kick-off meeting hosted by the EC brought together six projects – ARTURO, GLIOMATCH, HIT-GLIO, MULTIR, SPACETIME and THRIVE – collaborting under the EU Cancer Mission‘s Understanding Cancer. During this meeting, the projects discussed their common goals and work plan. More information on: https://gliomatch.eu/cluster/

GLIOMATCH 1st Consortium Meeting
2024-03-25 08:00 - 2024-03-27 17:00 | KUL, Leuven, Belgium
The GLIOMATCH project kick-off meeting took place from 25-27 March 2024 and was hosted by KU Leuven, the project coordinator, at the Faculty Club in Leuven, Belgium. This marks the first in-person gathering of the project’s 14 partner institutions.
